Curcumin in exfoliated layered double hydroxide nanoparticles: Pre-clinical evaluation as lung cancer nanomedicine
Rationally designed∼ 100 nm sized curcumin (CRC) loaded exfoliated layered double
hydroxide nanoparticles (X-LDH/CRC-NPs) have been tested for its suitability as …
hydroxide nanoparticles (X-LDH/CRC-NPs) have been tested for its suitability as …
Identification of a novel circ_0010235/miR-1249-3p/HOXA13 axis in lung adenocarcinoma
J Liu, Z Fu - Biochemical Genetics, 2022 - Springer
Lung adenocarcinoma (LUAD) is an aggressive malignancy with a poor prognosis. In this
study, we explored the critical role and mechanism of circ_0010235 in the pathogenesis of …
study, we explored the critical role and mechanism of circ_0010235 in the pathogenesis of …
[PDF][PDF] 槐耳清膏抑制非小细胞肺癌细胞增殖和血管新生的作用机制研究
隗玉川， 程万宏， 应朝辉， 于林， 王艳俊 - 现代生物医学进展, 2022 - biomed.cnjournals.com
摘要目的: 探讨槐耳清膏抑制非小细胞肺癌(NSCLC) 细胞增殖和血管新生的作用机制. 方法:
选择对数生长期的NSCLC 细胞, 经过传代培养成细胞株后采用随机法分成低剂量组 …
选择对数生长期的NSCLC 细胞, 经过传代培养成细胞株后采用随机法分成低剂量组 …
SDF-1 promotes metastasis of NSCLC by enhancing chemoattraction of megakaryocytes through the PI3K/Akt signaling pathway
Y Ai, C Wan, Z Chen, Y Wang, W Zhao, W Huang - Journal of Biosciences, 2024 - Springer
Lung cancer (LC) is the leading cause of cancer-associated deaths worldwide, among
which non-small-cell lung cancer (NSCLC) accounts for 80%. Stromal cell-derived factor-1 …
which non-small-cell lung cancer (NSCLC) accounts for 80%. Stromal cell-derived factor-1 …
SENP1 Aberrance and its linkage to clinical features, adjuvant regimen, and prognosis in patients with Surgical Non-small Cell Lung Cancer receiving adjuvant …
Q Yang, M Yang, J Zhang, Y Ma - Frontiers in Surgery, 2022 - frontiersin.org
Background Small ubiquitin-like modifier-specific protease 1 (SENP1) plays vital roles in
cancer progression and chemoresistance, but its prognostic value in non-small cell lung …
cancer progression and chemoresistance, but its prognostic value in non-small cell lung …
Genomic landscape and actionable mutations of brain metastases derived from non–small cell lung cancer: A systematic review
LJ Andrews, ZA Thornton, R Saleh… - Neuro-Oncology …, 2023 - academic.oup.com
Background Brain metastases derived from non–small cell lung cancer (NSCLC) represent
a significant clinical problem. We aim to characterize the genomic landscape of brain …
a significant clinical problem. We aim to characterize the genomic landscape of brain …
Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma
D Zhang, Y Zhao - Frontiers in Genetics, 2023 - frontiersin.org
Introduction: This research explored the immune characteristics of natural killer (NK) cells in
lung adenocarcinoma (LUAD) and their predictive role on patient survival and …
lung adenocarcinoma (LUAD) and their predictive role on patient survival and …
[PDF][PDF] 雷火灸五脏背俞穴对气虚型非小细胞肺癌患者化疗后癌因性疲乏的临床疗效评价
覃芳媛， 王理槐， 彭廷云， 邓敏… - Progress in …, 2023 - biomed.cnjournals.com
摘要目的: 探讨雷火灸五脏背俞穴对气虚型非小细胞肺癌(NSCLC) 患者化疗后癌因性疲乏的
临床疗效. 方法: 选取2020 年3 月~ 2022 年5 月期间我院收治的NSCLC 患者93 例 …
临床疗效. 方法: 选取2020 年3 月~ 2022 年5 月期间我院收治的NSCLC 患者93 例 …
Analysis of Angiogenesis-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Lung Adenocarcinoma
Q Zhou, X Chen, Q Chen, L Hao - Critical Reviews™ in …, 2023 - dl.begellhouse.com
Tumor angiogenesis is considered to be an important part of the mechanism of tumor
progression and metastasis, and its specific function in lung adenocarcinoma has not been …
progression and metastasis, and its specific function in lung adenocarcinoma has not been …
[HTML][HTML] 肺癌EGFR-TKI 联合贝伐珠单抗治疗进展
谢志丹， 梁亚奇， 徐芹芹 - Advances in Clinical Medicine, 2022 - hanspub.org
近年来肺癌发病率及死亡率均占癌症首位, 其中约30%~ 40% 的患者在确诊时存在EGFR 突变,
靶向药物的研发使这部分患者的治疗有了新的更精准的方向, 多项实验证实EGFR-TKI …
靶向药物的研发使这部分患者的治疗有了新的更精准的方向, 多项实验证实EGFR-TKI …